David Gómez-Varela

Title: David Gómez-Varela: Innovator in Antibody Research

Introduction

David Gómez-Varela is a prominent inventor based in Del Mar, California. He is known for his significant contributions to the field of biotechnology, particularly in the development of antibodies targeting the mammalian EAG1 ion channel protein. His work has implications for diagnosing and treating various diseases.

Latest Patents

David holds a patent for "Antibodies directed to the mammalian EAG1 ion channel protein." This invention relates to a unique antibody, antibody fragment, or derivative that specifically binds to at least one epitope of the extracellular or intracellular domain of the mammalian EAG1 ion channel. The patent also covers nucleic acid molecules encoding these anti-EAG1 antibodies and methods for their preparation. Furthermore, it includes pharmaceutical compositions comprising these antibodies and their applications in diagnosing diseases, treating conditions, and assessing the presence of EAG1-expressing cells.

Career Highlights

David Gómez-Varela is associated with the Max Planck Society for the Advancement of Science, where he continues to push the boundaries of research in antibody development. His innovative work has garnered attention in the scientific community, contributing to advancements in medical research.

Collaborations

David has collaborated with notable scientists such as Walter Stühmer and Hendrik Knötgen. These partnerships have enhanced his research and expanded the impact of his inventions in the field.

Conclusion

David Gómez-Varela is a key figure in the development of targeted antibody therapies, with a focus on the EAG1 ion channel protein. His contributions are paving the way for new diagnostic and therapeutic approaches in medicine.